Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Adam M Moss, Alon Harris, Brent Siesky, Deepam Rusia, Kathleen M Williamson & Yochai Shoshani. (2010) Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients. Clinical Ophthalmology 4, pages 233-241.
Read now
Read now
Anne J Lee & Peter McCluskey. (2010) Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clinical Ophthalmology 4, pages 741-764.
Read now
Read now
Parul Ichhpujani & L Jay Katz. (2010) Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension. Drug, Healthcare and Patient Safety 2, pages 73-83.
Read now
Read now
B. Pajic, B. Pajic-Eggspuehler & I.O. Häfliger. (2010) Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma. Current Medical Research and Opinion 26:9, pages 2213-2219.
Read now
Read now
M. Orme, S. Collins, H. Dakin, S. Kelly & J. Loftus. (2010) Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension. Current Medical Research and Opinion 26:3, pages 511-528.
Read now
Read now
Henny JM Beckers, Jan SAG Schouten & Carroll AB Webers. (2009) Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 3, pages 593-599.
Read now
Read now
Antonio Martínez & Manuel Sánchez. (2007) Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides. Current Medical Research and Opinion 23:3, pages 595-599.
Read now
Read now
Articles from other publishers (24)
Ari Stoner, Alon Harris, Francesco Oddone, Aditya Belamkar, Alice Chandra Verticchio Vercellin, Joshua Shin, Ingrida Januleviciene & Brent Siesky. (2022) Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?. British Journal of Ophthalmology 106:10, pages 1332-1337.
Crossref
Crossref
Yulan Lu, Zhong Chen, Jie He, Lan Li, Rong Chen & Jili Chen. (2022) Anti-Glaucoma Effects of Timolol and Bimatoprost in Novel Ocular Hypertension Model in Rats. International Journal of Pharmacology 18:2, pages 279-291.
Crossref
Crossref
P.A. Bezdetko. (2022) Again about carbonic anhydrase inhibitors: modern aspects of the use of ICA in ophthalmology. Archive of Ukrainian Ophthalmology 9:2, pages 64-71.
Crossref
Crossref
T. N. Malishevskaya, T. N. Kiseleva, A. S. Vlasova & E. K. Eliseeva. (2021) Impact of combination of local carbonic anhydrase inhibitors and beta-blockers on intraocular pressure, visual functions and eye hemodynamics in primary open-angle glaucoma. Russian Ophthalmological Journal 14:2, pages 96-102.
Crossref
Crossref
HebaMagdy Ahmed El-Saied, WaelE. Abd Elhalim, Mohamed Abdelhamid & KareemBakr Elessawy. (2021) Changes in peripapillary blood flow after dorzolamide 2%/timolol 0.5% versus latanoprost 0.005%/timolol 0.5% using optical coherence tomography angiography. Egyptian Retina Journal 8:1, pages 19.
Crossref
Crossref
N. I. Kurysheva. (2020) Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I. Ophthalmology in Russia 17:3s, pages 542-549.
Crossref
Crossref
T. N. Yurieva & S. I. Zhukova. (2019) OCT angiography in a comprehensive assessment of hypotensive therapy effectiveness in patients with primary open-angle glaucoma. Russian Ophthalmological Journal 12:3, pages 43-49.
Crossref
Crossref
Mustafa Eliacik, Sevil Karaman Erdur, Inci Baltepe Altıok, Gokhan Gulkilik, Cemile Anil Aslan & Faruk Kaya. (2016) Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma. The Kaohsiung Journal of Medical Sciences 32:1, pages 38-43.
Crossref
Crossref
Antonio Martinez. 2016. Glaucoma Imaging. Glaucoma Imaging
123
147
.
S Kremmer, M Iliadou, G Anastassiou, M Schallenberg, W Vilser, K.P Steuhl & J.M Selbach. (2014) Influence of Latanoprost on Retinal Microcirculation in Glaucoma. The Open Ophthalmology Journal 8:1, pages 60-66.
Crossref
Crossref
Michelle Orme, Sarah Collins & Jane Loftus. (2012) Long-term Medical Management of Primary Open-Angle Glaucoma and Ocular Hypertension in the UK. Journal of Glaucoma 21:7, pages 433-449.
Crossref
Crossref
I Marjanovic, N Milic, A Martinez & J Benitez-del-Castillo. (2012) Retrobulbar hemodynamic parameters in open-angle and angle-closure glaucoma patients. Eye 26:4, pages 523-528.
Crossref
Crossref
Ivan Marjanovic, Natasa Milic & Antonio Martinez. (2011) The Impact of Intraocular Pressure Reduction on Retrobulbar Hemodynamic Parameters in Patients with Open-Angle Glaucoma. European Journal of Ophthalmology 22:1, pages 77-82.
Crossref
Crossref
Ingeborg Stalmans, Evelien Vandewalle, Douglas R. Anderson, Vital P. Costa, Ronald E. P. Frenkel, Gerhard Garhofer, Juan Grunwald, Konstantin Gugleta, Alon Harris, Christopher Hudson, Ingrida Januleviciene, Larry Kagemann, Hélène Kergoat, John V. Lovasik, Ines Lanzl, Antonio Martinez, Quan D. Nguyen, Niklas Plange, Herbert A. Reitsamer, Mitra Sehi, Brent Siesky, Oliver Zeitz, Selim Orgül & Leopold Schmetterer. (2011) Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmologica 89:8, pages e609-e630.
Crossref
Crossref
Delan Jinapriya, Ayako Anraku, Tariq Alasbali, Graham E. Trope & Yvonne M. Buys. (2011) Evaluation of investigator bias in industry-funded clinical trials of latanoprost. Canadian Journal of Ophthalmology 46:6, pages 531-536.
Crossref
Crossref
Antonio Martínez & Manuel Sanchez‐Salorio. (2010) Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open‐angle glaucoma. Acta Ophthalmologica 88:5, pages 541-552.
Crossref
Crossref
Antonio MartínezManuel Sánchez-Salorio. (2009) A Comparison of the Long-Term Effects of Dorzolamide 2% and Brinzolamide 1%, Each Added to Timolol 0.5%, on Retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients. Journal of Ocular Pharmacology and Therapeutics 25:3, pages 239-248.
Crossref
Crossref
Jin-Wei ChengGui-Lin XiRui-Li WeiJi-Ping CaiYou Li. (2009) Efficacy and Tolerability of Latanoprost Compared to Dorzolamide Combined with Timolol in the Treatment of Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized, Controlled Trials. Journal of Ocular Pharmacology and Therapeutics 25:1, pages 55-64.
Crossref
Crossref
Brent Siesky, Alon Harris, Edward Brizendine, Clarice Marques, Jennifer Loh, Joseph Mackey, Jennifer Overton & Peter Netland. (2009) Literature Review and Meta-Analysis of Topical Carbonic Anhydrase Inhibitors and Ocular Blood Flow. Survey of Ophthalmology 54:1, pages 33-46.
Crossref
Crossref
Hae Y. ParkNa Y. LeeJie H. KimChan K. Park. (2008) Intraocular Pressure Lowering, Change of Antiapoptotic Molecule Expression, and Neuroretinal Changes by Dorzolamide 2%/Timolol 0.5% Combination in a Chronic Ocular Hypertension Rat Model. Journal of Ocular Pharmacology and Therapeutics 24:6, pages 563-572.
Crossref
Crossref
Antonio Martinez & Manuel Sanchez. (2008) Retrobulbar hemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology 246:9, pages 1341-1349.
Crossref
Crossref
Ozlem Gurbuz Koz, Arzu Ozsoy, Alper Yarangumeli, S. Kenan Kose & Gulcan Kural. (2007) Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial. Acta Ophthalmologica Scandinavica 85:8, pages 838-843.
Crossref
Crossref
A. Martinez & M. Sanchez. (2007) Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients. International Journal of Clinical Practice 61:5, pages 815-825.
Crossref
Crossref
James E Frampton & Caroline M Perry. (2006) Topical Dorzolamide 2%/Timolol 0.5% Ophthalmic Solution. Drugs & Aging 23:12, pages 977-995.
Crossref
Crossref